FilingReader Intelligence
ZIM Laboratories closes Middle East subsidiary, revenue falls 12%
August 7, 2025 at 03:10 PM UTC•By FilingReader AI
ZIM Laboratories' board approved closure of its Middle East DMCC subsidiary, pending UAE regulatory approval.
The company reported Q1 FY26 operating income of ₹718m, down 12.3% year-over-year due to geopolitical issues affecting Middle East and Bangladesh markets. Exports fell 15.2% to ₹602m.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
BSE:ZIMLAB•Bombay Stock Exchange
News Alerts
Get instant email alerts when ZIM Laboratories publishes news
Free account required • Unsubscribe anytime